Galmed Pharmaceuticals (EOCN) Income from Continuing Operations (2013 - 2024)
Galmed Pharmaceuticals (EOCN) recorded Income from Continuing Operations of -$316,000 in FY2025, compared with -$400,000 in FY2024.
Powered by 
Analysis
Galmed Pharmaceuticals (EOCN) Income from Continuing Operations (2013 - 2024) Analysis & Trends
Starting with FY2011, Galmed Pharmaceuticals' Income from Continuing Operations history includes 15 years.
- Annual Income from Continuing Operations has ranged from -$400,000 in FY2024 to $32.88 million in FY2021 over the past five years.
- Per Business Quant data, EOCN's Income from Continuing Operations was -$400,000 in FY2024, $7.47 million in FY2023 (-57.8%), $17.69 million in FY2022 (-46.2%) and $32.88 million in FY2021 (+14.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Galmed Pharmaceuticals | 406,071.97 | 406,071.97 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 653,000.00 |
| Jun 30, 2023 | 579,000.00 |
| Mar 31, 2023 | -592,000.00 |
| Jun 30, 2022 | 318,000.00 |
| Mar 31, 2022 | -240,000.00 |
| Jun 30, 2020 | 5.82 Mn |
| Mar 31, 2020 | 6.86 Mn |
| Dec 31, 2019 | 8.29 Mn |
| Sep 30, 2019 | 4.51 Mn |
| Jun 30, 2019 | 4.70 Mn |
| Mar 31, 2019 | 4.59 Mn |
| Dec 31, 2018 | 3.71 Mn |
| Sep 30, 2018 | 809,000.00 |
| Jun 30, 2018 | 2.69 Mn |
| Mar 31, 2018 | 2.61 Mn |
| Dec 31, 2017 | 3.64 Mn |
| Sep 30, 2017 | 2.80 Mn |
| Jun 30, 2017 | 2.69 Mn |
| Mar 31, 2017 | 3.37 Mn |
| Dec 31, 2016 | 4.83 Mn |
API Access
Galmed Pharmaceuticals Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=EOCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "EOCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=EOCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();